Atu027: Phase Ib/IIa final data

Final data from the Phase IIa portion of the open-label, German Phase Ib/IIa Atu027-I-02 trial in 23 patients with locally advanced or metastatic pancreatic adenocarcinoma showed that twice-weekly Atu...